Home Business Ford U.S. Sales Fall 6.6% as Automaker Phases Out Escape and Corsair
BusinessWorld

Ford U.S. Sales Fall 6.6% as Automaker Phases Out Escape and Corsair

Share
Ford U.S. Sales Fall 6.6% as Automaker Phases Out Escape and Corsair
Share

Ford Motor’s U.S. vehicle sales fell 6.6% in the third quarter of 2026, as the automaker phased out its Escape and Lincoln Corsair crossover models amid changing consumer demand.

Ford sold 509,764 vehicles during the quarter, compared with the same period a year earlier. The decline comes as high gasoline prices encourage more American consumers to consider hybrid vehicles, while affordability remains a challenge because of elevated vehicle prices.

Ford’s truck sales, however, increased 0.5% to 315,112 units. Sales of its Maverick pickup, which is available with a hybrid powertrain, climbed more than 20% to 41,970 units.

The company said it is seeing stronger demand for hybrid powertrains, including on its F-150 pickup.

The shift comes as Asian automakers with larger hybrid line-ups gain ground in the U.S. market. Toyota and Honda have benefited from consumers seeking vehicles with lower fuel consumption as gasoline prices remain elevated.

The average price paid for a new vehicle reached $50,089 in August, up 1.9% from a year earlier, adding to pressure on household budgets.

See also  McLaren to Create 1,000 UK Jobs With £450m Technology Investment
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Digital Payment Use Rises Among Nigerians Despite Fraud Experiences, Report Reveals

The 2026 State of Inclusive Instant Payment Systems in Africa (SIIPS) report,...

Banking Sell-Off Drags NGX Down as Investors Lose N406 Billion

Investors in Nigeria's stock market lost N406.34 billion in market value on...

African Businesses Face Shutdowns, Liquidation and Licence Revocations in Third Quarter of 2026

Several businesses across Africa faced shutdowns, insolvency proceedings and regulatory action in...

New pancreatic cancer pill raises hope as tumours disappear in early trials

A new daily pill, daraxonrasib, has shown promising results in early clinical...